No insider purchase over the last 90 days. The latest, by KAITIN KENNETH I, was filed 01 Apr 2026.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 59 declarations
At Curis Inc, James R. Mcnab, a director, signs 13 filings, all sales, the largest of which follow one another in April 2017: EUR 135,469 on April 25, EUR 110,051 on April 21 and EUR 99,140 on April 24. In all, 30 sales (28 with an amount) weigh EUR 1,157,517, median EUR 17,093, against 4 purchases (3 with an amount) for EUR 70,458, median EUR 20,775: 12% purchases.
The largest purchases are from November 2017: Ali Fattaey PhD, president and CEO, EUR 44,942 on November 15, and Marc Rubin, a director, EUR 20,775 on November 16. Kenneth I. Kaitin, a director, bought EUR 4,741 on March 31, 2026 and has 10 filings, 3 of them sales. James E. Dentzer, president and CEO, signs 10, of which 8 sales; Martyn D. Greenacre, a director, 9.
In all, 14 insiders filed 59 times between January 7, 2016 and April 1, 2026, with a peak of 21 in 2017. The record holds 11 grants and 9 option exercises. Filings are published a median of 2 days after the trade. Over the last twelve months there are 6 filings, 1 purchase. Insiders hold 6.5% of the capital.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 9.4 m USD | -7.6 m USD | -0.58 USD | 10-K |
| Dec 2024 | 10.9 m USD | -43.4 m USD | -6.88 USD | 10-K |
| Dec 2023 | 10.0 m USD | -47.4 m USD | -8.96 USD | 10-K |
| Dec 2022 | 10.2 m USD | -56.7 m USD | -12.14 USD | 10-K |
| Dec 2021 | 10.6 m USD | -45.4 m USD | 0.50 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.